Key result
Novel p38 inhibitor LASSBio-1824 reduces pulmonary vascular resistance and RV hypertrophy in experimental PH.
Why the study?
Current vasodilator therapies for pulmonary hypertension do not directly target cardiovascular remodeling associated with disease progression, highlighting the need for new remodeling-targeted treatments.
Answers are grounded in this paper and cite their sources.
Mitogen-activated protein kinase (MAPK) signaling is strongly implicated in cardiovascular remodeling in pulmonary hypertension (PH) and right ventricle (RV) failure. The effects of a newly designed p38 inhibitor, LASSBio-1824, were investigated in experimentally induced PH. Male Wistar rats were exposed to hypoxia and SU5416 (SuHx), and normoxic rats were used as controls. Oral treatment was performed for 14 days with either vehicle or LASSBio-1824 (50 mg/kg). Pulmonary vascular resistance and RV structure and function were assessed by echocardiography and catheterization. Histological, immunohistochemical and Western blot analysis of lung and RV were performed to investigate cardiovascular remodeling and inflammation. Treatment with LASSBio-1824 normalized vascular resistance by attenuating vessel muscularization and endothelial dysfunction. In the heart, treatment decreased RV systolic pressure, hypertrophy and collagen content, improving cardiac function. Protein content of TNF-α, iNOS, phosphorylated p38 and caspase-3 were reduced both in lung vessels and RV tissues after treatment and a reduced activation of transcription factor c-fos was found in cardiomyocytes of treated SuHx rats. Therefore, LASSBio-1824 represents a potential candidate for remodeling-targeted treatment of PH.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2022) studied Pulmonary Arterial Hypertension (n=15). LASSBio-1824 vs. Vehicle (DMSO) was evaluated on Pulmonary vascular resistance (PAT/PET ratio) (p=<0.05). Treatment with the novel p38 inhibitor LASSBio-1824 significantly reduced pulmonary vascular resistance, right ventricular hypertrophy, and tissue inflammation in rats with experimentally induced pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: